Risma Ikawaty

Dr. Risma Ikawaty

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2023 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
SPSulistyo Emantoko Dwi Putra
Sulistyo Emantoko Dwi Putra
FHFarizky Martriano Humardani
Farizky Martriano Humardani
LMLisa Thalia Mulyanata
Lisa Thalia Mulyanata
LTLady Theresa Adeodata Tanaya
Lady Theresa Adeodata Tanaya
HWHeru Wijono
Heru Wijono
RIRisma Ikawaty
Risma Ikawaty

17 August 2022 in Radiology Case Reports
Verified
Journal Article
Open access
JBJordan Bakhriansyah
Jordan Bakhriansyah
ISI Gede Parama Gandi Semita
I Gede Parama Gandi Semita
ISI Gde Rurus Suryawan
I Gde Rurus Suryawan
YAYusuf Azmi
Yusuf Azmi
ISIrfan Deny Sanjaya
Irfan Deny Sanjaya
FAFiras Farisi Alkaff
Firas Farisi Alkaff
Thymoma is the most common primary anterior mediastinum mass with various clinical manifestations, and one of the manifestations is pericardial effusion. While pericardial effusion in thymoma is usually serous, it can become purulent when an infection occurs in a nearby organ, albeit rare. In this report, we present a rare case of a 27-year-old woman who had purulent pericarditis secondary to an advanced thymoma. The patient came to the emergency department with the chief complaints of worsening chest discomfort, non-productive cough, and fever in the past 2 weeks. The patient was diagnosed with thymoma 5 months prior. Based on the examinations, it was discovered that the patient had pericarditis. After the pericardiocentesis was performed and the fluid was examined, the patient was diagnosed with purulent pericarditis secondary to thymoma. The patient was then treated with intravenous antibiotic and pericardial drain. Unfortunately, the patient's condition deteriorated, and the patient died on the fifth day of hospitalization. This case highlights an infrequent but potentially life-threatening complication of thymoma. In addition, thymic pathologies should be included as a rare etiology in the differential diagnosis of purulent pericardial effusion.

25 February 2025 in Eurasian Journal of Medicine and Oncology
Verified
Journal Article
Open access
PDF file
FHFarizky Martriano Humardani
Farizky Martriano Humardani
SPSulistyo Emantoko Dwi Putra
Sulistyo Emantoko Dwi Putra
RNRatih Asmana Ningrum
Ratih Asmana Ningrum
IWI. Wayan Arsana Wiyasa
I. Wayan Arsana Wiyasa
LMLisa Thalia Mulyanata
Lisa Thalia Mulyanata
AEAgustina Tri Endharti
Agustina Tri Endharti
The scientific literature extensively discusses the role of single nucleotide polymorphisms (SNPs) in the etiology of type 2 diabetes (T2D). However, the specific mechanisms linking SNPs to T2D remain incompletely understood. Historically, the development of T2D has been attributed to insulin resistance and dysfunction in insulin secretion. The primary aim of this review is to assess the risk of T2D based on its pathophysiology through genetic analysis, with a particular focus on Asian populations, given the ethnic variability in SNPs, and to propose personalized therapeutic strategies. This review identified SNPs involved in insulin regulation, including those related to insulin synthesis and secretion, insulin degradation, peripheral insulin sensitivity, and circadian rhythms. Furthermore, SNPs influencing the response to T2D medications, including biguanides, thiazolidinediones, non-sulfonylurea secretagogues, and sulfonylureas have been identified. Identification of SNPs associated with T2D risk and drug responses suggests that genetic screening could play a key role in both prevention and treatment, offering personalized strategies based on an individual’s genetic profile. Moreover, early identification of SNPs before disease manifestation presents an opportunity for prevention, as epigenetic factors influenced by lifestyle changes may alter disease risk. Further studies are needed to fully understand the mechanisms linking SNPs to T2D and to develop personalized therapies, with a particular focus on Asian populations.

13 December 2024 in Heliyon
Verified
Journal Article
Open access
SPSulistyo Emantoko Dwi Putra
Sulistyo Emantoko Dwi Putra
Farizky HumardaniFarizky Humardani
Farizky Humardani
HSHikmawan Wahyu Sulistomo
Hikmawan Wahyu Sulistomo
YAYulanda Antonius
Yulanda Antonius
JJJonathan Jonathan
Jonathan Jonathan
RIRisma Ikawaty
Risma Ikawaty
Nasopharyngeal cancer (NPC), although rare in young individuals worldwide, is significantly influenced by the Epstein-Barr virus (EBV). Considering EBV's widespread prevalence, understanding its role in NPC's future occurrence, disease progression, clinical symptoms, metastatic tendencies, and prognosis is crucial. In this study, we extensively analyzed two young patients with NPC, who displayed distinct clinical features. We utilized Whole Exome Sequencing (WES), concentrating on EBV-interacting receptors, and applied advanced in silico methods for a deeper investigation. These methods included structural analysis via SWISS-MODEL, stability assessments using PremPS, and molecular docking studies with ClusPro. Our focus was to analyze genetic variants identified by WES and confirm EBV presence using RT-qPCR. Our comparative study between the two subjects showed that the first had milder symptoms and a lower metastasis than the second. In the first subject, we identified unique genetic variants: NRP1 c.536T > C (p.Val179Ala) and MYH9 c.4876A > G (p.Ile1626Val). Notably, the NRP1 p.Val179Ala variant caused structural changes leading to protein instability. Molecular docking suggested that this variant enhances interaction more than the wild-type. RT-qPCR validation of EBV showed lower levels in subject one (mutant-NRP1) compared to subject two (wild-type-NRP1). This finding implies that the p.Val179Ala variant in subject one could obstruct EBV entry, possibly leading to less severe clinical symptoms Our research provides new insights into the genetic factors influencing the clinical presentation of NPC, identifying promising targets for further research and therapeutic interventions. However, additional validation in a larger cohort is required to elucidate the broader impact of these genetic variants.